Neonatal Seizure Monitoring: Electrographic Seizures Without Clinical Correlate
A 3-day-old term infant with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia is monitored with continuous video-EEG. The background shows a discontinuous pattern with a suppressed interburst interval. Over 40 minutes the EEG shows three electrographic seizures: rhythmic 2-3 Hz sharp waves over the left central-temporal region lasting 90-120 seconds, with no visible clinical movement on video and no change in heart rate. The infant is sedated with morphine and paralyzed? No - not paralyzed, but hypotonic with minimal spontaneous movement. The team asks whether these are 'real' seizures, whether to treat, and whether the lack of clinical correlate means they are unimportant.
1. How do you determine whether these electrographic events are true seizures, and what is the significance of the absence of a clinical correlate?
Read the worked answer
Confirming seizures: True neonatal electrographic seizures show evolution in frequency, amplitude, and morphology, with a clear onset and offset, and are distinguished from rhythmic artifacts (e.g., patting, ventilator, ECG) by their focal field, evolution, and lack of time-locking to a mechanical source. The events described (rhythmic 2-3 Hz sharp waves, focal left central-temporal, 90-120 s with evolution) are consistent with electrographic seizures.
Absence of clinical correlate: In neonates, many seizures - especially after HIE and during sedation/neuromuscular blockade - are electrographic only ('electroclinical dissociation'). The lack of motor manifestation does not make them benign; electrographic seizures can cause secondary injury and are associated with worse outcome. Conversely, some clinical movements in neonates are not accompanied by EEG seizures (e.g., brainstem release phenomena, myoclonus), so EEG is required to distinguish.
Judgment: Treat based on the electrographic seizure burden, not on visible movement. The lack of clinical correlate is expected in this setting and is not a reason to withhold treatment.
2. What monitoring and treatment decisions follow, and what pitfalls arise during therapeutic hypothermia?
Read the worked answer
Monitoring: Continue continuous video-EEG through the cooling and rewarming period, because seizure burden often peaks during rewarming and after sedation is reduced. Quantify seizure burden and background (discontinuity, suppression) as prognostic markers.
Treatment: Treat prolonged or repetitive electrographic seizures (commonly with phenobarbital first-line, then levetiracetam or others per protocol), with attention to respiratory depression and hemodynamics. Avoid over-sedation that obscures the EEG.
Pitfalls: (1) Hypothermia alters drug metabolism and clearance - dosing must account for this. (2) Rewarming can unmask or provoke seizures - do not stop monitoring prematurely. (3) Background suppression from hypothermia/sedation can be mistaken for seizure or vice versa; use evolution and field to distinguish. (4) Do not rely on clinical observation alone to detect seizures in this population.